Research ExplorerPublicationsLong-COVID or long before? Neurocognitive deficits in people...

Long-COVID or long before? Neurocognitive deficits in people with COVID-19

Standard

Long-COVID or long before? Neurocognitive deficits in people with COVID-19. / Baumeister, Anna; Göritz, Anja S; Benoy, Charles; Jelinek, Lena; Moritz, Steffen.

In: PSYCHIAT RES, Vol. 317, 114822, 11.2022, p. 114822.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Baumeister, A, Göritz, AS, Benoy, C, Jelinek, L & Moritz, S 2022, 'Long-COVID or long before? Neurocognitive deficits in people with COVID-19', PSYCHIAT RES, vol. 317, 114822, pp. 114822. https://doi.org/10.1016/j.psychres.2022.114822

APA

Baumeister, A., Göritz, A. S., Benoy, C., Jelinek, L., & Moritz, S. (2022). Long-COVID or long before? Neurocognitive deficits in people with COVID-19. PSYCHIAT RES, 317, 114822. [114822]. https://doi.org/10.1016/j.psychres.2022.114822

Vancouver

Baumeister A, Göritz AS, Benoy C, Jelinek L, Moritz S. Long-COVID or long before? Neurocognitive deficits in people with COVID-19. PSYCHIAT RES. 2022 Nov;317:114822. 114822. https://doi.org/10.1016/j.psychres.2022.114822

Bibtex

@article{32849ad8c85d4e5bbf4c84bdd91cfe98,
title = "Long-COVID or long before? Neurocognitive deficits in people with COVID-19",
abstract = "In connection with COVID-19 disease, evidence of persisting psychiatric and neurocognitive effects is accumulating. To examine long COVID symptoms, baseline data from 2015 (i.e., before the pandemic) and follow-up data from 2021 from 428 participants were compared. Participants with COVID-19 reported more subjective neurocognitive complaints in the follow-up, but this did not correspond to the test performance. Also, greater depressive symptoms compared with the no-COVID group were reported. However, these complaints must be put into perspective when considering the baseline data, since complaints were present before the COVID infection. Thus, premorbid performance as well as psychological factors should be considered when discussing long COVID.",
author = "Anna Baumeister and G{\"o}ritz, {Anja S} and Charles Benoy and Lena Jelinek and Steffen Moritz",
year = "2022",
month = nov,
doi = "10.1016/j.psychres.2022.114822",
language = "English",
volume = "317",
pages = "114822",
journal = "PSYCHIAT RES",
issn = "0165-1781",
publisher = "Elsevier Ireland Ltd",

}

RIS

TY - JOUR

T1 - Long-COVID or long before? Neurocognitive deficits in people with COVID-19

AU - Baumeister, Anna

AU - Göritz, Anja S

AU - Benoy, Charles

AU - Jelinek, Lena

AU - Moritz, Steffen

PY - 2022/11

Y1 - 2022/11

N2 - In connection with COVID-19 disease, evidence of persisting psychiatric and neurocognitive effects is accumulating. To examine long COVID symptoms, baseline data from 2015 (i.e., before the pandemic) and follow-up data from 2021 from 428 participants were compared. Participants with COVID-19 reported more subjective neurocognitive complaints in the follow-up, but this did not correspond to the test performance. Also, greater depressive symptoms compared with the no-COVID group were reported. However, these complaints must be put into perspective when considering the baseline data, since complaints were present before the COVID infection. Thus, premorbid performance as well as psychological factors should be considered when discussing long COVID.

AB - In connection with COVID-19 disease, evidence of persisting psychiatric and neurocognitive effects is accumulating. To examine long COVID symptoms, baseline data from 2015 (i.e., before the pandemic) and follow-up data from 2021 from 428 participants were compared. Participants with COVID-19 reported more subjective neurocognitive complaints in the follow-up, but this did not correspond to the test performance. Also, greater depressive symptoms compared with the no-COVID group were reported. However, these complaints must be put into perspective when considering the baseline data, since complaints were present before the COVID infection. Thus, premorbid performance as well as psychological factors should be considered when discussing long COVID.

U2 - 10.1016/j.psychres.2022.114822

DO - 10.1016/j.psychres.2022.114822

M3 - SCORING: Journal article

C2 - 36116186

VL - 317

SP - 114822

JO - PSYCHIAT RES

JF - PSYCHIAT RES

SN - 0165-1781

M1 - 114822

ER -